Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

Children with cancer had slightly more unusual facial shapes than healthy kids, but not enough to easily tell them apart.

Alopecia areata causes significant psychological distress in cancer patients, needing integrated care.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Hormone therapy for breast cancer often leads to sexual issues like vaginal dryness and decreased libido.

Hair loss causes emotional distress, leading to high spending on treatments, with Minoxidil and Propecia being common but having side effects.

Steroid-producing capabilities in certain cancers may contribute to treatment resistance.

Puerto Rican children with cancer often experience symptoms like irritability, nausea, and hair loss, and need better education and continuous symptom management.

Targeting colon cancer stem cells might lead to better treatment results.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

The document concludes that accurate diagnosis and personalized treatment are important for skin problems in women with PCOS.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

ScalpEye accurately diagnoses scalp issues like dandruff and hair loss.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

The document suggests that targeting the hormone DHT could be a more effective treatment for prostate cancer than targeting testosterone.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

Blood tests confirmed a baby in the womb had a CMV infection.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Diagnosing PCOS in teenagers should focus on signs of excess male hormones and not rely solely on ovarian ultrasound or irregular periods, and should be reassessed in adulthood.

Chemotherapy causes hair loss starting soon after treatment begins and recovers about 3 months after ending, while tamoxifen does not significantly affect hair growth.

Treating excessive hair in women requires a holistic approach, including medical, aesthetic, and emotional support.